Identifier |
20230312_nanos_posters_078 |
Title |
Relapsing-Remitting Multiple Sclerosis and Intermediate Uveitis Treated with Natalizumab |
Creator |
Jieun Kang; Tamer Ghanayem; Alexis Flowers; Subramaniam Sriram; Akshay Thomas; Sapna Gangaputra; Shailee Shah |
Affiliation |
(JK) (TG) (SS) (SS) Vanderbilt University Medical Center; (SF) (SG) Vanderbilt Eye institute; (AT) Tennessee Retina |
Subject |
Neuro-ophthalmology & Systemic Disease (eg. MS, MG, Thyroid); Demylinating Disease |
Description |
Natalizumab is a disease-modifying therapy (DMT) efficacious in relapsing-remitting multiple sclerosis (RRMS)[1]. Intermediate uveitis is found to coexist with RRMS at higher rates than the general population and often requires prolonged high-dose steroids[2] or immunomodulatory therapy. We report a series of three patients with RRMS and concomitant uveitis effectively treated with natalizumab. |
Date |
2023-03-14 |
Language |
eng |
Format |
application/pdf |
Type |
Text |
Source |
2023 North American Neuro-Ophthalmology Society Annual Meeting |
Relation is Part of |
NANOS Annual Meeting 2023: Poster Session I: Neuro-Ophthalmic Disorders of Neurologic and Systemic Diseases |
Collection |
Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu |
Publisher |
Spencer S. Eccles Health Sciences Library, University of Utah |
Holding Institution |
North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416 |
Rights Management |
Copyright 2023. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
ARK |
ark:/87278/s6gmkdjw |
Setname |
ehsl_novel_nam |
ID |
2335284 |
Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6gmkdjw |